Skip to main content
Erschienen in: Annals of Surgical Oncology 9/2018

03.07.2018 | Breast Oncology

Why Do Reoperation Rates Vary So Much After Lumpectomy for Breast Cancer? Examining the Reoperation Puzzle at the Massachusetts General Hospital

verfasst von: Jeffrey Landercasper, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Excerpt

Focusing on reoperations after initial lumpectomy for breast cancer, Valero and colleagues report the end results of the Massachusetts General Hospital (MGH) experience in this issue of the Annals of Surgical Oncology. Reoperations occurred for 114 (22.9%) of 490 patients with stage 1 or 2 breast cancer undergoing lumpectomy at MGH in 2014. The unadjusted reoperation rates among eight surgeons ranged from 16 to 40%. After multivariate risk adjustment, significant differences by individual surgeon persisted. …
Literatur
1.
Zurück zum Zitat 1. McCahill LE, Single RM, Aiello Bowles EJ, et al. Variability in reexcision following breast conservation surgery. JAMA. 2012;307:467–75.CrossRefPubMed 1. McCahill LE, Single RM, Aiello Bowles EJ, et al. Variability in reexcision following breast conservation surgery. JAMA. 2012;307:467–75.CrossRefPubMed
2.
Zurück zum Zitat 2. Wilke LG, Czechura T, Wang C, et al. Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004–2010. JAMA Surg. 2014;149:1296–305.CrossRefPubMed 2. Wilke LG, Czechura T, Wang C, et al. Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004–2010. JAMA Surg. 2014;149:1296–305.CrossRefPubMed
3.
Zurück zum Zitat 3. Jeevan R, Cromwell DA, Trivella M, et al. Reoperation rates after breast-conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ. 2012;345:e4505.CrossRefPubMedPubMedCentral 3. Jeevan R, Cromwell DA, Trivella M, et al. Reoperation rates after breast-conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ. 2012;345:e4505.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat van Leeuwen MT, Falster MO, Vajdic CM, et al. Reoperation after breast-conserving surgery for cancer in Australia: statewide cohort study of linked hospital data. BMJ Open. 2018;8:e020858-2017-020858. van Leeuwen MT, Falster MO, Vajdic CM, et al. Reoperation after breast-conserving surgery for cancer in Australia: statewide cohort study of linked hospital data. BMJ Open. 2018;8:e020858-2017-020858.
5.
Zurück zum Zitat 5. Isaacs AJ, Gemignani ML, Pusic A, Sedrakyan A. Association of breast conservation surgery for cancer with 90-day reoperation rates in New York State. JAMA Surg. 2016;151:648–55.CrossRefPubMed 5. Isaacs AJ, Gemignani ML, Pusic A, Sedrakyan A. Association of breast conservation surgery for cancer with 90-day reoperation rates in New York State. JAMA Surg. 2016;151:648–55.CrossRefPubMed
6.
Zurück zum Zitat 6. Ong WL, Schouwenburg MG, van Bommel ACM, et al. A standard set of value-based patient-centered outcomes for breast cancer: the International Consortium for Health Outcomes Measurement (ICHOM) initiative. JAMA Oncol. 2017;3:677–85.CrossRefPubMed 6. Ong WL, Schouwenburg MG, van Bommel ACM, et al. A standard set of value-based patient-centered outcomes for breast cancer: the International Consortium for Health Outcomes Measurement (ICHOM) initiative. JAMA Oncol. 2017;3:677–85.CrossRefPubMed
7.
Zurück zum Zitat 7. Landercasper J, Bennie B, Parsons BM, et al. Fewer reoperations after lumpectomy for breast cancer with neoadjuvant rather than adjuvant chemotherapy: a report from the National Cancer Database. Ann Surg Oncol. 2017;24:1507–15.CrossRefPubMedPubMedCentral 7. Landercasper J, Bennie B, Parsons BM, et al. Fewer reoperations after lumpectomy for breast cancer with neoadjuvant rather than adjuvant chemotherapy: a report from the National Cancer Database. Ann Surg Oncol. 2017;24:1507–15.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat 8. Houssami N, Macaskill P, Marinovich ML, Morrow M. The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol. 2014;21:717–30.CrossRefPubMedPubMedCentral 8. Houssami N, Macaskill P, Marinovich ML, Morrow M. The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol. 2014;21:717–30.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat 9. Marinovich ML, Azizi L, Macaskill P, et al. The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol. 2016;23:3811–21.CrossRefPubMedPubMedCentral 9. Marinovich ML, Azizi L, Macaskill P, et al. The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol. 2016;23:3811–21.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat 10. Chagpar AB, Killelea BK, Tsangaris TN, et al. A randomized, controlled trial of cavity shave margins in breast cancer. N Engl J Med. 2015;373:503–10.CrossRefPubMedPubMedCentral 10. Chagpar AB, Killelea BK, Tsangaris TN, et al. A randomized, controlled trial of cavity shave margins in breast cancer. N Engl J Med. 2015;373:503–10.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat 11. Landercasper J, Attai D, Atisha D, et al. Toolbox to reduce lumpectomy reoperations and improve cosmetic outcome in breast cancer patients: the American Society of Breast Surgeons Consensus Conference. Ann Surg Oncol. 2015;22:3174–83.CrossRefPubMedPubMedCentral 11. Landercasper J, Attai D, Atisha D, et al. Toolbox to reduce lumpectomy reoperations and improve cosmetic outcome in breast cancer patients: the American Society of Breast Surgeons Consensus Conference. Ann Surg Oncol. 2015;22:3174–83.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat 12. Del Turco MR, Ponti A, Bick U, et al. Quality indicators in breast cancer care. Eur J Cancer. 2010;46:2344–56.CrossRefPubMed 12. Del Turco MR, Ponti A, Bick U, et al. Quality indicators in breast cancer care. Eur J Cancer. 2010;46:2344–56.CrossRefPubMed
13.
Zurück zum Zitat 13. Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer. Ann Surg Oncol. 2014;21:704–16.CrossRefPubMed 13. Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer. Ann Surg Oncol. 2014;21:704–16.CrossRefPubMed
14.
Zurück zum Zitat 14. Morrow M, Van Zee KJ, Solin LJ, et al. Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ. Ann Surg Oncol. 2016;23:3801–10.CrossRefPubMedPubMedCentral 14. Morrow M, Van Zee KJ, Solin LJ, et al. Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ. Ann Surg Oncol. 2016;23:3801–10.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat 15. Landercasper J, Whitacre E, Degnim AC, Al-Hamadani M. Reasons for reexcision after lumpectomy for breast cancer: insight from the American Society of Breast Surgeons Mastery(SM) Database. Ann Surg Oncol. 2014;21:3185–91.CrossRefPubMed 15. Landercasper J, Whitacre E, Degnim AC, Al-Hamadani M. Reasons for reexcision after lumpectomy for breast cancer: insight from the American Society of Breast Surgeons Mastery(SM) Database. Ann Surg Oncol. 2014;21:3185–91.CrossRefPubMed
16.
Zurück zum Zitat 16. Guidi AJ, Tworek JA, Mais DD, Souers RJ, Blond BJ, Brown RW. Breast specimen processing and reporting with an emphasis on margin evaluation: a College of American Pathologists survey of 866 laboratories. Arch Pathol Lab Med. 2018;142:496–506.CrossRefPubMed 16. Guidi AJ, Tworek JA, Mais DD, Souers RJ, Blond BJ, Brown RW. Breast specimen processing and reporting with an emphasis on margin evaluation: a College of American Pathologists survey of 866 laboratories. Arch Pathol Lab Med. 2018;142:496–506.CrossRefPubMed
17.
Zurück zum Zitat 17. Birkmeyer JD, Finks JF, O’Reilly A, et al. Surgical skill and complication rates after bariatric surgery. N Engl J Med. 2013;369:1434–42.CrossRefPubMed 17. Birkmeyer JD, Finks JF, O’Reilly A, et al. Surgical skill and complication rates after bariatric surgery. N Engl J Med. 2013;369:1434–42.CrossRefPubMed
Metadaten
Titel
Why Do Reoperation Rates Vary So Much After Lumpectomy for Breast Cancer? Examining the Reoperation Puzzle at the Massachusetts General Hospital
verfasst von
Jeffrey Landercasper, MD
Publikationsdatum
03.07.2018
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 9/2018
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6609-0

Weitere Artikel der Ausgabe 9/2018

Annals of Surgical Oncology 9/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.